Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about COVID/19 Coronavirus

Recent news which mentions COVID/19 Coronavirus

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Another Clinical Trial Setback For Rigel Pharma's Lead Program, This Time For COVID-19
Tickers RIGL
Tags Briefs Biotech Movers
From Benzinga
Pfizer's Q3 Earnings Surpasses Estimates, Lifts Forecasts For COVID-19 Vaccine Sales By $2B
Tickers PFE
Tags Market News why it's moving Pre/Market Outlook
From Benzinga
European Regulator Grants Complete Approval To AstraZeneca's COVID-19 Vaccine
Tickers AZN AZNCF
Tags AZNCF General COVID/19 Vaccine
From Benzinga
Inovio Pharma Stops Work On INO-4800 As COVID-19 Heterologous Booster
Tickers INO
Tags COVID/19 Vaccine Small Cap General
From Benzinga
National Institutes of Health's Long COVID Initiative To Assess Pfizer's Antiviral Pill As Potential Treatment
Tickers PFE
Tags Market News General Health Care
From Benzinga
Vaccine Makers Mull Price Increase For COVID-19 Boosters Amid Falling Demand
Tickers BNTX MRNA NVAX PFE
Tags PFE Briefs Biotech
From Benzinga
Boston University's COVID-19 Created In Lab Research Comes Under Scrutiny
Tickers AZN BNTX GSK JNJ
Tags News JNJ LLY
From Benzinga
Vaccine Wastage: Switzerland Throws Away Some 9M Expired Moderna COVID-19 Vaccines
Tickers MRNA
Tags Government Briefs Biotech
From Benzinga
European Regulatory Authority Backs Approval For Moderna's New Omicron Targeted COVID-19 Booster
Tickers MRNA
Tags News Large Cap Trading Ideas
From Benzinga
FDA Gives Emergency Nod To Novavax's Adjuvanted COVID-19 Booster Dose
Tickers NVAX
Tags Benzinga Biotech Briefs
From Benzinga
Moderna's Omicron-Adapted Booster Maintains Response Through Three Months
Tickers MRNA
Tags MRNA Market News News
From Benzinga
RedHill Biopharma Shares Surge New Treatment Patent For Its Late-Stage COVID-19 Candidate
Tickers RDHL
Tags RDHL Market News News
From Benzinga
This Addiction Drug Shows Some Potential Against Long COVID Symptoms
Tickers GSK HGEN PFE VIR
Tags Briefs PFE Benzinga
From Benzinga
Moderna Inks Deal For Updated COVID Shots For Low Income Countries
Tickers MRNA
Tags COVID/19 Vaccine General Biotech
From Benzinga
Once Favored By Late Shinzo Abe, Japan Culls Development On Repurposed COVID-19 Treatment
Tickers FUJIF FUJIY
Tags Market News FUJIF FUJIY
From Benzinga
Pfizer/BioNTech's Updated Omicron Adapted COVID-19 Shot Increases Neutralizing Antibodies Above Pre-Booster Levels
Tickers BNTX PFE
Tags PFE News Large Cap
From Benzinga
Yet Another Good News For Moderna, FDA Approves Its New Omicron Adapted COVID-19 Shot
Tickers MRK MRNA
Tags General COVID/19 Vaccine Briefs
From Benzinga
Novavax Prototype COVID-19 Vaccine Data Shows Benefit Against Variants
Tickers NVAX
Tags Briefs Biotech Benzinga
From Benzinga
US Health Official Says Updated COVID-19 Boosters Should Offer Protection Amid Tracking Emerging Variants
Tickers MRNA PFE
Tags General COVID/19 Vaccine Biotech
From Benzinga
Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests
Tickers RHHBF RHHBY RHHVF
Tags Biotech Benzinga Briefs
From Benzinga
Cocrystal Pharma Advances One Of Its COVID-19 Antiviral Treatment Candidate
Tickers COCP
Tags Market News News Health Care
From Benzinga
AstraZeneca-Oxford University Partnered Nasal COVID-19 Vaccine Flunks Human Trial
Tickers AZN AZNCF
Tags Briefs Benzinga Biotech
From Benzinga
Pfizer's Executive Says European COVID-19 Vaccine Contract Negotiations Did Not Happen Over Text Message
Tickers BNTX PFE
Tags COVID/19 Vaccine General Government
From Benzinga
Swiss Health Agency Approves Pfizer, Novavax's Omicron Adapted COVID-19 Boosters
Tickers NVAX PFE
Tags Briefs PFE Benzinga
From Benzinga
Rebound In COVID-19 Symptoms After Pfizer's Antiviral Pill Might Be Due To Stronger Immune Response
Tickers PFE
Tags Benzinga Health Care COVID/19 Coronavirus
From Benzinga
Oramed Pharmaceuticals' Oral COVID-19 Vaccine Candidate Shows Safety, Immunogenicity In Early Study
Tickers ORMP
Tags General COVID/19 Vaccine Market News
From Benzinga
UK Study Shows Merck's COVID-19 Antiviral Pill Did Not Cut Hospitalization Risk
Tickers MRK
Tags MRK General Market News
From Benzinga
Eiger BioPharma Shuns Plans For FDA Emergency Use Nod For COVID-19 Treatment
Tickers EIGR
Tags EIGR Market News News
From Benzinga
Moderna Says No To China's Request To Handover COVID-19 Vaccine Technology: Report
Tickers MRNA
Tags Market News MRNA Media
From Benzinga
Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China
Tickers MRK PFE
Tags Biotech Health Care COVID/19 Coronavirus
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.